[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE229337T1 - Analgetika, einen cholezystokinin antagonisten und ein opioid enthaltend - Google Patents

Analgetika, einen cholezystokinin antagonisten und ein opioid enthaltend

Info

Publication number
ATE229337T1
ATE229337T1 AT98949092T AT98949092T ATE229337T1 AT E229337 T1 ATE229337 T1 AT E229337T1 AT 98949092 T AT98949092 T AT 98949092T AT 98949092 T AT98949092 T AT 98949092T AT E229337 T1 ATE229337 T1 AT E229337T1
Authority
AT
Austria
Prior art keywords
opioid
antagonist
cholecystokin
analgesics containing
analgesics
Prior art date
Application number
AT98949092T
Other languages
English (en)
Inventor
Leslie Lars Iversen
Original Assignee
Panos Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panos Therapeutics Ltd filed Critical Panos Therapeutics Ltd
Application granted granted Critical
Publication of ATE229337T1 publication Critical patent/ATE229337T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Electrotherapy Devices (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT98949092T 1997-10-15 1998-10-12 Analgetika, einen cholezystokinin antagonisten und ein opioid enthaltend ATE229337T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9721746.7A GB9721746D0 (en) 1997-10-15 1997-10-15 Compositions
PCT/GB1998/003076 WO1999018967A1 (en) 1997-10-15 1998-10-12 Analgesic compositions

Publications (1)

Publication Number Publication Date
ATE229337T1 true ATE229337T1 (de) 2002-12-15

Family

ID=10820524

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98949092T ATE229337T1 (de) 1997-10-15 1998-10-12 Analgetika, einen cholezystokinin antagonisten und ein opioid enthaltend

Country Status (8)

Country Link
EP (1) EP1023072B1 (de)
JP (1) JP2001519396A (de)
AT (1) ATE229337T1 (de)
AU (1) AU9547598A (de)
DE (1) DE69810146T2 (de)
ES (1) ES2189252T3 (de)
GB (1) GB9721746D0 (de)
WO (1) WO1999018967A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050192220A1 (en) * 2001-02-05 2005-09-01 Gevys Pharmaceuticas Ltd. Composition and method for potentiating drugs
GB0201367D0 (en) * 2002-01-22 2002-03-13 Ml Lab Plc Composition
GB0208129D0 (en) * 2002-04-09 2002-05-22 Ml Lab Plc Method of treatment
US6713470B2 (en) * 2002-01-22 2004-03-30 Ml Laboratories Plc Method of treatment
GB0207091D0 (en) * 2002-03-26 2002-05-08 Ml Lab Plc Method of treatment
ITRM20020194A1 (it) 2002-04-09 2003-10-09 Sigma Tau Healthscience Spa Composizione utile per aumentare la concentrazione e la motilita' degli spermatozoi e migliorarne la morfologia nell'uomo.
GB0213198D0 (en) * 2002-06-10 2002-07-17 Ml Lab Plc Method of treatment
WO2005007114A2 (en) * 2003-07-14 2005-01-27 Creagri, Inc. Method of treating diabetes type ii
AU2004285327A1 (en) * 2003-10-21 2005-05-12 Arakis Ltd. The use of non-opiates for the potentation of opiates
US20090286832A1 (en) * 2008-05-15 2009-11-19 Kiichiro Nabeta Narcotic emulsion formulations for treatment of surgical pain
FR2934953B1 (fr) 2008-08-14 2011-01-21 Commissariat Energie Atomique Nanoemulsions de nanocristaux
FR2934955B1 (fr) 2008-08-14 2011-07-08 Commissariat Energie Atomique Encapsulation d'agents therapeutiques lipophiles ou amphiphiles dans des nanoemulsions
FR2934954B1 (fr) 2008-08-14 2011-07-22 Commissariat Energie Atomique Emulsion fluorescente de vert d'indocyanine
GB0818473D0 (en) 2008-10-08 2008-11-12 Probio Nutraceuticals As Composition
MX2011007885A (es) 2009-02-26 2011-12-08 Techno Guard Co Ltd Formulaciones de emulsion de narcoticos para tratamiento de dolor por cancer.
GB201006175D0 (en) * 2010-04-14 2010-06-02 Ayanda As Composition
GB201006200D0 (en) * 2010-04-14 2010-06-02 Ayanda As Composition
US9132096B1 (en) 2014-09-12 2015-09-15 Alkermes Pharma Ireland Limited Abuse resistant pharmaceutical compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1564039A (en) * 1976-12-09 1980-04-02 Berger F Analgesic compositions comprising dextropropoxyphene and benzodiazepines
IE57892B1 (en) * 1984-06-25 1993-05-05 Rotta Research Lab Glutamic and aspartic acid derivatives
US4797286A (en) * 1985-11-12 1989-01-10 Eli Lilly And Company Orally administerable sustained release pharmaceutical formulations
CA2013755C (en) * 1989-04-05 1993-11-30 Simon Benita Medicinal emulsions

Also Published As

Publication number Publication date
JP2001519396A (ja) 2001-10-23
GB9721746D0 (en) 1997-12-10
WO1999018967A1 (en) 1999-04-22
ES2189252T3 (es) 2003-07-01
DE69810146T2 (de) 2003-11-13
EP1023072B1 (de) 2002-12-11
EP1023072A1 (de) 2000-08-02
AU9547598A (en) 1999-05-03
DE69810146D1 (de) 2003-01-23

Similar Documents

Publication Publication Date Title
ATE229337T1 (de) Analgetika, einen cholezystokinin antagonisten und ein opioid enthaltend
EE05180B1 (et) Asaindooli sisaldav farmatseutiline kompositsioon raviotstarbeliseks kasutamiseks, asaindoolid ning nende kasutamine ravimite valmistamiseks, mis on ette n„htud proteiinikinaasi kataltilise toime p„rssimiseks
NZ319531A (en) An analgesic synergistic composition containing a sub-analgesic dose of a mu opioid agonist and a kappa-2 opiod agonist
EP1091732A4 (de) Arzneistoffverabreichungssystem mit brauseaktivität zur oralen verabreichung
HUP0000299A3 (en) Pharmaceutical formulations for sustained drug delivery
AU4334700A (en) Pharmaceutical dosage form for pulsatile delivery of methylphenidate
EE9700241A (et) Farmatseutiline kompositsioon transdermaalseks manustamiseks
IL135886A0 (en) Topical compositions for nsai drug delivery
DK0938316T3 (da) Opioidantagonistholdig galenisk formulering
GR1002983B (el) Συσκευη διαδερμικης χορηγησης των φεντανιλ και σουφεντανιλ με ηλεκτρομεταφορα.
ATE493115T1 (de) Pharmazeutische zusammensetzungen enthaltend ein opioidanalgetikum
TR200103613T2 (tr) Burun içinden tatbik edilen morfini içeren farmasötik formülasyonlar ve yöntemler.
TR199900336T2 (xx) EAA antagonistleri olarak tetrahidrokinolin t�revleri.
DE60102590D1 (de) Darreichungsformen zur behandlung von oralen mykosen
NO20042758L (no) Fremgangsmate for behandling av en pasient som krever analgesi.
NO20022013L (no) Innretninger for transdermal legemiddellevering
AU2001280057A8 (en) Pharmaceutical carriers and compositions for transdermal drug delivery
BR0016654A (pt) Composto, método para o tratamento da dor, e, composição farmacêutica
ATE240097T1 (de) Pharmaceutische zusammensetzung enthaltend (+)- ephedrin und einen h1 rezeptor antagonisten
CA89010S (en) Injector for administration of pharmaceutical agents
LT99148A (en) Drug delivery devices and pharmaceutical composition for treatment wasting syndromes
FI960435A (fi) Lääkkeiden transdermaalisen antotapaan tarkoitettu koostumus
FI964663A0 (fi) Farmaceutisk analgetisk komposition foer lokal administrering
JO1881B1 (en) Formula II for multi unit disc calibration
ZA9960B (en) A stable isotonic pharmaceutical formulation for storage and therapeutic administration.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1023072

Country of ref document: EP

REN Ceased due to non-payment of the annual fee